Brooke Nichols, PhD, MSc, is a health economist and infectious disease mathematical modeller. She is jointly appointed as an Assistant Professor at the Department of Medical Microbiology, AMC and the Department of Global Health, Boston University School of Public Health.

Her research focuses on HIV and other infectious disease treatment and prevention in sub-Saharan Africa through mathematical and geospatial modelling for efficient resource allocation. Her current work includes mathematical modelling of SARS-CoV-2 transmission in low- and middle-income countries to optimise diagnostic and therapeutic resources. She currently co-leads the global Access to COVID-19 Tools Accelerator’s diagnostic modelling consortium aimed at improving the impact and efficiency of rapid antigen testing strategies for SARS-CoV-2. At Amsterdam UMC, she leads the Nichols Lab, which is guided by the mission to further develop the field of quantitative implementation science that provides policymakers with implementable insights that can be used to ensure scarce global healthcare resources are effectively used to maximise population health.

As a Postdoctoral Fellow at the Erasmus MC, she researched the cost-effectiveness of HIV prevention, treatment and care in the Netherlands including the cost of the Dutch HIV epidemic and the cost-effectiveness of pre-exposure prophylaxis (PrEP) use among men who have sex with men (MSM). From 2016-2019, Dr Nichols was also a resident at the Health Economics and Epidemiology Research Office (HE2RO) in Johannesburg, South Africa, where her research focused on the interface between HIV/TB modelling, health economics and health policy/implementation in South Africa, Zambia, Malawi, Lesotho and Zimbabwe. Her work has been published in The Lancet Infectious Diseases, Nature, and AIDS.